| Hilar cholangiocarcinoma: current management F Ito, CS Cho, LF Rikkers, SM Weber Annals of surgery 250 (2), 210-218, 2009 | 330 | 2009 |
| Resection of hilar cholangiocarcinoma: concomitant liver resection decreases hepatic recurrence F Ito, R Agni, RJ Rettammel, MJ Been, CS Cho, DM Mahvi, LF Rikkers, ... Annals of surgery 248 (2), 273-279, 2008 | 219 | 2008 |
| Radiotherapy potentiates the therapeutic efficacy of intratumoral dendritic cell administration S Teitz-Tennenbaum, Q Li, S Rynkiewicz, F Ito, MA Davis, CJ Mcginn, ... Cancer research 63 (23), 8466-8475, 2003 | 196 | 2003 |
| Anti-CD137 monoclonal antibody administration augments the antitumor efficacy of dendritic cell-based vaccines F Ito, Q Li, AB Shreiner, R Okuyama, MN Jure-Kunkel, ... Cancer research 64 (22), 8411-8419, 2004 | 139 | 2004 |
| The utility of intraoperative bilateral internal jugular venous sampling with rapid parathyroid hormone testing F Ito, R Sippel, J Lederman, H Chen Annals of surgery 245 (6), 959-963, 2007 | 106 | 2007 |
| Overcoming primary and acquired resistance to anti-PD-L1 therapy by induction and activation of tumor-residing cDC1s T Oba, MD Long, T Keler, HC Marsh, H Minderman, SI Abrams, S Liu, F Ito Nature communications 11 (1), 5415, 2020 | 101 | 2020 |
| T-cell CX3CR1 expression as a dynamic blood-based biomarker of response to immune checkpoint inhibitors T Yamauchi, T Hoki, T Oba, V Jain, H Chen, K Attwood, S Battaglia, ... Nature communications 12 (1), 1402, 2021 | 98 | 2021 |
| Antitumor effector B cells directly kill tumor cells via the Fas/FasL pathway and are regulated by IL‐10 H Tao, L Lu, Y Xia, F Dai, Y Wang, Y Bao, SK Lundy, F Ito, Q Pan, ... European journal of immunology 45 (4), 999-1009, 2015 | 96 | 2015 |
| Polarization effects of 4-1BB during CD28 costimulation in generating tumor-reactive T cells for cancer immunotherapy Q Li, A Carr, F Ito, S Teitz-Tennenbaum, AE Chang Cancer research 63 (10), 2546-2552, 2003 | 92 | 2003 |
| CX3CR1–CD8+ T cells are critical in antitumor efficacy but functionally suppressed in the tumor microenvironment T Yamauchi, T Hoki, T Oba, H Saito, K Attwood, MS Sabel, AE Chang, ... JCI insight 5 (8), 2020 | 58 | 2020 |
| Adoptive Transfer of CD8+ T Cells Generated from Induced Pluripotent Stem Cells Triggers Regressions of Large Tumors Along with Immunological Memory H Saito, K Okita, AE Chang, F Ito Cancer research 76 (12), 3473-3483, 2016 | 54 | 2016 |
| Cancer immunotherapy: current status and future directions F Ito, AE Chang Surgical Oncology Clinics 22 (4), 765-783, 2013 | 53 | 2013 |
| Generation of tumor antigen-specific iPSC-derived thymic emigrants using a 3D thymic culture system R Vizcardo, ND Klemen, SMR Islam, D Gurusamy, N Tamaoki, D Yamada, ... Cell reports 22 (12), 3175-3190, 2018 | 46 | 2018 |
| Handlebar hernia with intra-abdominal extraluminal air presenting as a novel form of traumatic abdominal wall hernia: report of a case H Shiomi, T Hase, S Matsuno, M Izumi, T Tatsuta, F Ito, A Kishida, T Tani, ... Surgery today 29, 1280-1284, 1999 | 44 | 1999 |
| Immune adjuvant activity of pre-resectional radiofrequency ablation protects against local and systemic recurrence in aggressive murine colorectal cancer F Ito, AW Ku, MJ Bucsek, JB Muhitch, T Vardam-Kaur, M Kim, DT Fisher, ... PLoS One 10 (11), e0143370, 2015 | 42 | 2015 |
| Antitumor reactivity of anti-CD3/anti-CD28 bead-activated lymphoid cells: implications for cell therapy in a murine model F Ito, A Carr, H Svensson, J Yu, AE Chang, Q Li Journal of Immunotherapy 26 (3), 222-233, 2003 | 39 | 2003 |
| Transabdominal preperitoneal robotic inguinal hernia repair F Ito, D Jarrard, JC Gould Journal of laparoendoscopic & advanced surgical techniques 18 (3), 397-399, 2008 | 35 | 2008 |
| Clinical characteristics, time course, treatment and outcomes of patients with immune checkpoint inhibitor-associated myocarditis I Puzanov, P Subramanian, YV Yatsynovich, DM Jacobs, MR Chilbert, ... Journal for ImmunoTherapy of Cancer 9 (6), 2021 | 34 | 2021 |
| Water: a simple solution for tumor spillage F Ito, M Camoriano, M Seshadri, SS Evans, JM Kane, JJ Skitzki Annals of surgical oncology 18, 2357-2363, 2011 | 29 | 2011 |
| In situ delivery of iPSC-derived dendritic cells with local radiotherapy generates systemic antitumor immunity and potentiates PD-L1 blockade in preclinical poorly immunogenic … T Oba, K Makino, R Kajihara, T Yokoi, R Araki, M Abe, H Minderman, ... Journal for immunotherapy of cancer 9 (5), 2021 | 27 | 2021 |
